InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by LaRocca John, Conseiller Juridique. Director active across 2 companies, notably Aerie Pharmaceuticals INC. Aggregated, 9 reports have been recorded. Activity tracked since 14 August 2021. The latest transaction was disclosed on 17 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
21,500 sharesCommon StockSEC:0001732197-25-000005:0
21,500 shares0Common StockSEC:0001415889-25-001874:0
53,585 shares@ US$15.2592.6% of flowCommon StockSEC:0001209191-22-058180:0
771 shares@ US$11.571.0% of flowCommon StockSEC:0001209191-22-045976:0
19,015 shares0Common StockSEC:0001209191-22-020655:0
1,973 shares@ US$6.0019.2% of flowCommon StockSEC:0001209191-22-012251:0
768 shares@ US$7.249.0% of flowCommon StockSEC:0001209191-22-008228:0
1,206 shares@ US$7.0513.7% of flowCommon StockSEC:0001209191-22-007897:0
765 shares@ US$14.7017.7% of flowCommon StockSEC:0001209191-21-051897:0
9 of 9 declarations
About LaRocca John
John LaRocca is General Counsel at Aerie Pharmaceuticals Inc. He is responsible for the legal and regulatory matters of the company, ensuring compliance and protecting the company's interests.
